Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Jeffrey D who wrote (8040)	7/12/1999 11:17:00 AM
From: manny t	Respond to of 9523

To: mrc (49885 ) From: manny t Monday, Jul 12 1999 11:16AM ET Reply # of 49888 PFE, FDA approves PFE drug for Heartworm prevention in dogs and cats. MW via eSignal Online. Manny T

To: Jeffrey D who wrote (8040)	7/12/1999 11:26:00 AM
From: David Post	Read Replies (2) \| Respond to of 9523

Is PFE reporting this afternoon after the bell?

To: Jeffrey D who wrote (8040)	7/12/1999 2:29:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 9523

Pfizer Combination Heartworm-Flea Treatment Wins FDA Approval Bloomberg News July 12, 1999, 12:52 p.m. ET Washington, July 12 (Bloomberg) -- Pfizer Inc., the world's No. 2 maker of animal drugs, won U.S. Food and Drug Administration approval for a topical treatment called Revolution, the first drug that combats both fleas and heartworms in dogs and cats. Revolution, a liquid that is placed on the animal's back monthly, is as effective as existing treatments for both fleas and heartworms, the FDA said. ''This is the most broad-spectrum drug that we've approved for dogs and cats,'' said Lisa Troutman, a medical officer in the FDA's Center for Veterinary Medicine. The drug also works against ear mites in cats and dogs, mange in dogs and roundworm and hookworm in cats. Revolution could help Pfizer add to the $1.3 billion in animal health sales it recorded in 1998. In addition to Revolution, Pfizer makes Rimadyl, a painkiller for dogs, and Anipryl, which stems the mental deterioration of aging dogs. Revolution is only available by prescription from a veterinarian, and it carries a small risk of side effects, the agency said. The most common side effect in the clinical trials was hair loss at the spot where the drug was administered. The FDA said it expects the drug will be introduced this fall. Pfizer shares rose 3/16 to 37 3/16 in midday trading.